Ujházy V, Reiner P, Farkas J, Skoda J
Neoplasma. 1977;24(3):259-61.
2.3-Dihydro-1,3-6H-oxazine-dione ("3-oxauracil") was tested against L1210 leukemia. The compound exhibited significant growth-inhibiting effect against this tumor both in vitro and also in vivo following daily intraperitoneal application.
2,3 - 二氢 - 1,3 - 6H - 恶嗪二酮(“3 - 氧代尿嘧啶”)针对L1210白血病进行了测试。该化合物在体外以及每日腹腔注射给药后的体内均对这种肿瘤表现出显著的生长抑制作用。